RNA interference with chemically modified siRNA

Hong Yan Zhang, Quan Du, Claes R Wahlestedt, Zicai Liang

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

siRNA has become an indispensable tool for functional characterization of genes. It has also demonstrated tremendous potential as a new generation of drug candidates. Although the technology works very well to a great panel of cells in vitro, it is still a challenge to translate the success into in vivo target validation easiness and, even more difficult, into therapeutic applications. With a number of chemically modified compounds under initial clinical trial from several commercial entities, the interests in chemical modification of siRNA have become heightened. In this review we have tried to touch on most of the chemical modifications of RNA that have been tested in the siRNA landscape, but maintained a focus on the backbone modifications, and 2′-modifications on the ribose ring. It is anticipated that more modifications and more systematic comparisons between different modifications will be performed to draw more educated conclusions over some of the modifications.

Original languageEnglish
Pages (from-to)893-900
Number of pages8
JournalCurrent Topics in Medicinal Chemistry
Volume6
Issue number9
DOIs
StatePublished - May 1 2006
Externally publishedYes

Fingerprint

RNA Interference
Small Interfering RNA
Chemical modification
RNA
Ribose
Genes
Clinical Trials
Technology
Pharmaceutical Preparations
Therapeutics

Keywords

  • Backbone modifications
  • Lactosylated-PEG-siRNA conjugates
  • Oligonucleotides
  • RNA sugar ring
  • Terminal modifications

ASJC Scopus subject areas

  • Medicine(all)
  • Chemistry(all)

Cite this

RNA interference with chemically modified siRNA. / Zhang, Hong Yan; Du, Quan; Wahlestedt, Claes R; Liang, Zicai.

In: Current Topics in Medicinal Chemistry, Vol. 6, No. 9, 01.05.2006, p. 893-900.

Research output: Contribution to journalArticle

Zhang, Hong Yan ; Du, Quan ; Wahlestedt, Claes R ; Liang, Zicai. / RNA interference with chemically modified siRNA. In: Current Topics in Medicinal Chemistry. 2006 ; Vol. 6, No. 9. pp. 893-900.
@article{6a0dc8bac8e2498680b717c2913b1807,
title = "RNA interference with chemically modified siRNA",
abstract = "siRNA has become an indispensable tool for functional characterization of genes. It has also demonstrated tremendous potential as a new generation of drug candidates. Although the technology works very well to a great panel of cells in vitro, it is still a challenge to translate the success into in vivo target validation easiness and, even more difficult, into therapeutic applications. With a number of chemically modified compounds under initial clinical trial from several commercial entities, the interests in chemical modification of siRNA have become heightened. In this review we have tried to touch on most of the chemical modifications of RNA that have been tested in the siRNA landscape, but maintained a focus on the backbone modifications, and 2′-modifications on the ribose ring. It is anticipated that more modifications and more systematic comparisons between different modifications will be performed to draw more educated conclusions over some of the modifications.",
keywords = "Backbone modifications, Lactosylated-PEG-siRNA conjugates, Oligonucleotides, RNA sugar ring, Terminal modifications",
author = "Zhang, {Hong Yan} and Quan Du and Wahlestedt, {Claes R} and Zicai Liang",
year = "2006",
month = "5",
day = "1",
doi = "10.2174/156802606777303676",
language = "English",
volume = "6",
pages = "893--900",
journal = "Current Topics in Medicinal Chemistry",
issn = "1568-0266",
publisher = "Bentham Science Publishers B.V.",
number = "9",

}

TY - JOUR

T1 - RNA interference with chemically modified siRNA

AU - Zhang, Hong Yan

AU - Du, Quan

AU - Wahlestedt, Claes R

AU - Liang, Zicai

PY - 2006/5/1

Y1 - 2006/5/1

N2 - siRNA has become an indispensable tool for functional characterization of genes. It has also demonstrated tremendous potential as a new generation of drug candidates. Although the technology works very well to a great panel of cells in vitro, it is still a challenge to translate the success into in vivo target validation easiness and, even more difficult, into therapeutic applications. With a number of chemically modified compounds under initial clinical trial from several commercial entities, the interests in chemical modification of siRNA have become heightened. In this review we have tried to touch on most of the chemical modifications of RNA that have been tested in the siRNA landscape, but maintained a focus on the backbone modifications, and 2′-modifications on the ribose ring. It is anticipated that more modifications and more systematic comparisons between different modifications will be performed to draw more educated conclusions over some of the modifications.

AB - siRNA has become an indispensable tool for functional characterization of genes. It has also demonstrated tremendous potential as a new generation of drug candidates. Although the technology works very well to a great panel of cells in vitro, it is still a challenge to translate the success into in vivo target validation easiness and, even more difficult, into therapeutic applications. With a number of chemically modified compounds under initial clinical trial from several commercial entities, the interests in chemical modification of siRNA have become heightened. In this review we have tried to touch on most of the chemical modifications of RNA that have been tested in the siRNA landscape, but maintained a focus on the backbone modifications, and 2′-modifications on the ribose ring. It is anticipated that more modifications and more systematic comparisons between different modifications will be performed to draw more educated conclusions over some of the modifications.

KW - Backbone modifications

KW - Lactosylated-PEG-siRNA conjugates

KW - Oligonucleotides

KW - RNA sugar ring

KW - Terminal modifications

UR - http://www.scopus.com/inward/record.url?scp=33744458689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744458689&partnerID=8YFLogxK

U2 - 10.2174/156802606777303676

DO - 10.2174/156802606777303676

M3 - Article

C2 - 16787282

AN - SCOPUS:33744458689

VL - 6

SP - 893

EP - 900

JO - Current Topics in Medicinal Chemistry

JF - Current Topics in Medicinal Chemistry

SN - 1568-0266

IS - 9

ER -